📜 iter-4360dd15-0025.log
16796 bytes
# Iter-0025 mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-25T23:38:22
# focus_node: n127 :: 筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选
========== TRANSCRIPT ==========
→ call task_view({"max_depth":6})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n· [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call search_memory({"limit":6,"mission_only":true,"query":"线粒体 干预 寿命终点 长寿 候选 mTOR 直接 寿命 证据"})
【tool:search_memory】
{"ok": true, "results": [{"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425153620000", "preview": "!! 下轮焦点（来自 mission `4360dd15` · Iter-0024） [n130] 审计线粒体干预是否具有与 mTOR 相当的直接寿命终点证据（路径：找到让人类长生不老的方法 > 筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选 > 审计线粒体干预是否具有与 mTOR 相当的直接寿命终点证据）"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时，应把“是否直接延长寿命/健康寿命”作为高优先级门槛，而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点，才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "候选筛选要用“干预 + 终点”双约束检索", "tags": "lesson method principle aging", "mission": "4360dd15", "modified": "20260425152851000", "preview": "筛选长寿候选时，检索必须同时约束“可操纵的干预”和“寿命/健康寿命终点”；只搜机制词通常会淹没在综述、计量分析和相关性论文里，难以产生可排序的证据。"}, {"title": "先证终点，再谈长寿", "tags": "lesson endpoint-classification citation-chain trial-audit", "mission": "4360dd15", "modified": "20260424204906000", "preview": "综述只用于定位试验；真正的证据必须落到单个 PMID 的主要终点是否直接是死亡、生存、健康寿命或失能自由生存。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境；PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425050740000", "preview": "筛选长寿瓶颈时，不要把“看起来更上游”当作高杠杆的充分条件；真正更值得优先的靶点，是那些被扰动后能同时恢复多个下游功能、并最好有健康寿命或寿命终点支持的节点。"}]}
→ call pubmed_search({"limit":8,"query":"(mitochondria OR mitochondrial OR mitophagy) lifespan mouse intervention aging longevity"})
→ call web_search({"limit":8,"query":"mitochondrial intervention lifespan mouse aging longevity study"})
→ call pubmed_search({"limit":8,"query":"mitochondrial-targeted intervention life span mice aging mdivi-1 skq1 nicotinamide riboside urolithin"})
→ call web_search({"limit":8,"query":"adult mouse mitochondrial intervention lifespan healthspan study publication"})
【tool:pubmed_search】
{"ok": true, "query": "(mitochondria OR mitochondrial OR mitophagy) lifespan mouse intervention aging longevity", "results": [{"pmid": "42011226", "title": "SRN-901, a Novel Longevity Drug, Extends Lifespan and Healthspan by Targeting Multiple Aging Pathways.", "source": "Drug Des Devel Ther", "pubdate": "2026", "authors": ["Weiss B", "Miranda DR", "Arrazati D", "Cao R", "Chen J", "Liu Y", "Brown D", "Marshall G"], "url": "https://pubmed.ncbi.nlm.nih.gov/42011226/"}, {"pmid": "41986945", "title": "Ghrelin Receptor Deletion or Pharmacological Inhibition Improves Muscle Function in Aging Male Mice.", "source": "Aging Cell", "pubdate": "2026 Apr", "authors": ["Kerr HL", "Krumm K", "Myree N", "Rybachok A", "Dacek E", "Irwin B", "Jiang S", "Caeiro L"], "url": "https://pubmed.ncbi.nlm.nih.gov/41986945/"}, {"pmid": "41931604", "title": "The longevity effects of reduced IGF-1 signaling depend on the stability of the mitochondrial genome.", "source": "Sci Adv", "pubdate": "2026 Apr 3", "authors": ["Shemtov SJ", "McGann E", "Carrillo L", "Lee S", "Anson H", "Hwang E", "Chung CS", "Weinert JL"], "url": "https://pubmed.ncbi.nlm.nih.gov/41931604/"}, {"pmid": "41660882", "title": "DRP1 in Reproduction and Reproductive Aging.", "source": "Biol Reprod", "pubdate": "2026 Feb 9", "authors": ["Huang CR", "Cheng YH", "Chang YC", "Weng PL", "Lan KC"], "url": "https://pubmed.ncbi.nlm.nih.gov/41660882/"}, {"pmid": "41457450", "title": "Exploring Splicing-Energy Axis Associations to Diet and Longevi
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
【tool:pubmed_search】
{"ok": true, "query": "mitochondrial-targeted intervention life span mice aging mdivi-1 skq1 nicotinamide riboside urolithin", "results": []}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call pubmed_search({"limit":10,"query":"SKQ1 lifespan mouse aging"})
→ call pubmed_search({"limit":10,"query":"MitoQ lifespan mouse aging"})
→ call pubmed_search({"limit":10,"query":"SS-31 lifespan mouse aging"})
→ call pubmed_search({"limit":10,"query":"mitophagy lifespan mouse genetic intervention aging"})
→ call pubmed_search({"limit":10,"query":"mitochondrial antioxidant lifespan mice longevity"})
【tool:pubmed_search】
{"ok": true, "query": "SKQ1 lifespan mouse aging", "results": [{"pmid": "31512417", "title": "[Comparative analysis of experimental data about the effects of various polyphenols on lifespan and aging.].", "source": "Adv Gerontol", "pubdate": "2019", "authors": ["Panchenko AV", "Tyndyk ML", "Fedoros EI", "Maydin MA", "Semenov AL", "Gubareva EA", "Golubev AG", "Anisimov VN"], "url": "https://pubmed.ncbi.nlm.nih.gov/31512417/"}, {"pmid": "28209927", "title": "Improved health-span and lifespan in mtDNA mutator mice treated with the mitochondrially targeted antioxidant SkQ1.", "source": "Aging (Albany NY)", "pubdate": "2017 Feb 15", "authors": ["Shabalina IG", "Vyssokikh MY", "Gibanova N", "Csikasz RI", "Edgar D", "Hallden-Waldemarson A", "Rozhdestvenskaya Z", "Bakeeva LE"], "url": "https://pubmed.ncbi.nlm.nih.gov/28209927/"}, {"pmid": "25519058", "title": "New data on programmed aging - slow phenoptosis.", "source": "Biochemistry (Mosc)", "pubdate": "2014 Oct", "authors": ["Skulachev MV", "Skulachev VP"], "url": "https://pubmed.ncbi.nlm.nih.gov/25519058/"}, {"pmid": "22166671", "title": "Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents.", "source": "Aging (Albany NY)", "pubdate": "2011 Nov", "authors": ["Anisimov VN", "Egorov MV", "Krasilshchikova MS", "Lyamzaev KG", "Manskikh VN", "Moshkin MP", "Novikov EA", "Popovich IG"], "url": "https://pubmed.ncbi.nlm.nih.gov/22166671/"}, {"pmid": "21269268", "title": "Mitochondrial-targeted plastoquinone derivati
【tool:pubmed_search】
{"ok": true, "query": "MitoQ lifespan mouse aging", "results": [{"pmid": "41632424", "title": "Novel multi-omic biomarkers to combat oocyte and ovarian aging.", "source": "Geroscience", "pubdate": "2026 Feb 3", "authors": ["Kordowitzki P", "Joshi S", "Gong X", "Ying AK", "Wyroba J", "Kochan J", "Haigis MC"], "url": "https://pubmed.ncbi.nlm.nih.gov/41632424/"}, {"pmid": "38851726", "title": "Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice.", "source": "Arthritis Res Ther", "pubdate": "2024 Jun 8", "authors": ["Poudel SB", "Ruff RR", "Yildirim G", "Miller RA", "Harrison DE", "Strong R", "Kirsch T", "Yakar S"], "url": "https://pubmed.ncbi.nlm.nih.gov/38851726/"}, {"pmid": "38535998", "title": "Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging.", "source": "Aging (Albany NY)", "pubdate": "2024 Mar 25", "authors": ["Poudel SB", "Frikha-Benayed D", "Ruff RR", "Yildirim G", "Dixit M", "Korstanje R", "Robinson L", "Miller RA"], "url": "https://pubmed.ncbi.nlm.nih.gov/38535998/"}, {"pmid": "38343826", "title": "Development of primary osteoarthritis during aging in genetically diverse UM-HET3 mice.", "source": "Res Sq", "pubdate": "2024 Jan 22", "authors": ["Poudel SB", "Ruff RR", "Yildirim G", "Miller RA", "Harrison DE", "Strong R", "Kirsch T", "Yakar S"], "url": "https://pubmed.ncbi.nlm.nih.gov/38343826/"}, {"pmid": "33145977", "title": "Rapamycin-mediated mouse lifespan extension: Late-life dosage
【tool:pubmed_search】
{"ok": true, "query": "SS-31 lifespan mouse aging", "results": [{"pmid": "41612464", "title": "SS-31 improves the quality of maternally aged oocytes by ameliorating mitochondrial function and metabolism.", "source": "J Ovarian Res", "pubdate": "2026 Jan 29", "authors": ["Xiong D", "Zhang Y", "Wei J", "Wang L", "Zhang G", "Yu L", "Zeng J", "Liu W"], "url": "https://pubmed.ncbi.nlm.nih.gov/41612464/"}]}
【tool:pubmed_search】
{"ok": true, "query": "mitophagy lifespan mouse genetic intervention aging", "results": []}
【tool:pubmed_search】
{"ok": true, "query": "mitochondrial antioxidant lifespan mice longevity", "results": [{"pmid": "41421349", "title": "Enhanced non-enzymatic H(2)S generation extends lifespan and healthspan in male mice.", "source": "Cell Metab", "pubdate": "2026 Feb 3", "authors": ["Cáliz-Molina MÁ", "López-Fernández-Sobrino R", "Pino-Pérez I", "Panadero-Morón C", "Vilches-Pérez MDC", "Camacho-Cabrera M", "García-Ruiz A", "Pérez-Rosendo L"], "url": "https://pubmed.ncbi.nlm.nih.gov/41421349/"}, {"pmid": "41205505", "title": "6-PPD induces mitochondrial dysfunction and reduces healthspan and lifespan through SKN-1 in Caenorhabditis elegans.", "source": "J Hazard Mater", "pubdate": "2025 Dec 5", "authors": ["Hyun M", "Rathor L", "Kim HJ", "Lee HJ", "McElroy T", "Ji M", "Choi MS", "Beck S"], "url": "https://pubmed.ncbi.nlm.nih.gov/41205505/"}, {"pmid": "41142020", "title": "Radioprotective Efficacy of Jujube Aqueous Extract and Arbutin: Synergistic Antioxidant and Anti-Apoptotic Mechanisms in Radiation Injury.", "source": "Food Sci Nutr", "pubdate": "2025 Oct", "authors": ["Wang L", "Yang H", "Zhou X", "Zhao Y", "Li L", "Wang N"], "url": "https://pubmed.ncbi.nlm.nih.gov/41142020/"}, {"pmid": "40872473", "title": "α-Ketoglutarate Attenuates Oxidative Stress-Induced Neuronal Aging via Modulation of the mTOR Pathway.", "source": "Pharmaceuticals (Basel)", "pubdate": "2025 Jul 22", "authors": ["Guan R", "Xue Z", "Huang K", "Zhao Y", "He G", "Dai Y", "Liang M", "Wen Y"], "url": "https://pubmed.ncbi.n
→ call write_note({"tags":["fact","lesson","principle","aging","triage"],"text":"!! 线粒体干预并非只有机制相关：存在直接寿命终点的具体正例\n''结论'': 线粒体并不是只能停留在代谢/细胞表型层面的候选；至少有''线粒体靶向抗氧化剂''在小鼠中报告了直接寿命终点改善，例如：\n# PMID 22166671：SkQ1（线粒体靶向 plastoquinone derivative）延长啮齿动物寿命。\n# PMID 28209927：SkQ1 在 mtDNA mutator mice 中改善健康寿命并延长寿命。\n# PMID 31521745：MitoQ 在 aged 3xTg-AD mice 中报告延长寿命，同时改善认知/病理表型。\n''方法论教训'': 在筛选长寿瓶颈时，线粒体这一大类不能被一概排除；但它的证据形态往往比 rapamy)
【tool:write_note】
{"ok": true, "path": "/root/Sisyphus/wiki/tiddlers/Mitochondrial_interventions_have_direct_lifespan-endpoint_positives_but_evidence_is_heterogeneous.tid", "title": "Mitochondrial interventions have direct lifespan-endpoint positives, but evidence is heterogeneous"}
→ call task_done({"id":"n130","result":"定位到线粒体靶向抗氧化干预的直接寿命终点正例：SkQ1（PMID 22166671, 28209927）与 MitoQ（PMID 31521745），说明线粒体并非纯机制候选，但证据高度异质、远不如 rapamycin 统一。"})
【tool:task_done】
{"ok": true, "id": "n130", "status": "done", "next_focus": "n127"}
【assistant】
已完成 n130：确认线粒体干预里确实有直接寿命终点正例，但证据形态不如 mTOR/rapamycin 统一。
要点：
- **SkQ1**：PMID **22166671**、**28209927**，有延寿/健康寿命改善报告。
- **MitoQ**：PMID **31521745**，在 aged 3xTg-AD mice 中报告延长寿命并改善病理。
- 结论不是“线粒体不行”，而是“线粒体有正例，但高度异质、背景依赖强，和 mTOR 这种基线正例不同”。
我也把这条可复用结论沉淀进记忆了。
<NEXT_FOCUS>筛选蛋白稳态/自噬/线粒体中的第三个高杠杆长寿瓶颈候选</NEXT_FOCUS>
========== REFLECTION ==========
{
"progress": "确认了线粒体靶向干预并非纯机制候选：SkQ1 和 MitoQ 至少各有直接寿命终点正例，但同类证据分散且不统一。",
"failure": "先前把线粒体作为一整类怀疑过头，忽略了同一大类里“少数有终点、更多只有表型”的异质性。",
"lesson": {
"worthy": true,
"title": "不要把整类机制一刀切地排除",
"tags": [
"lesson",
"principle",
"aging",
"triage"
],
"text": "在长寿候选筛选里，不能因为一个机制大类里多数成员只停留在表型层面，就把整类直接判死；更好的做法是按具体干预逐个审计寿命/健康寿命终点。即使存在正例，也要把“单篇正例”和“可重复、可泛化的类效应”分开看。"
},
"next_focus": "逐个审计 SkQ1、MitoQ、SS-31 是否存在独立重复的寿命终点，而不是只停留在单篇正例。"
}